Latest AI and machine learning research in chemotherapy for healthcare professionals.
Adoptive cell therapy with tumor-infiltrating lymphocytes (ACT-TILs) involves autologous TILs that are expanded ex vivo and then reinfused into the patient as a personalized form of therapy. For bladder cancer patients, there is a unique opportunity to deliver TILs locally, through intravesical administration, without systemic cytotoxic chemotherapy to induce lymphodepletion. Improved selection of...
Recurrence related to poor prognosis is a leading cause of mortality in patients with breast cancer (BC). The MammaPrint (MP) genomic assay is designed to stratify recurrence risk and evaluate chemotherapy benefits for early-stage HR+/HER2- BC patients. However, MP fails to reveal spatial tumor morphology and is limited by high costs. In this study, we establish a BC MP cohort and develop CPMP, a ...
Triple-negative breast cancer (TNBC) is an aggressive malignancy with limited targeted therapies and variable responses to conventional chemotherapy, ...
The tumor microenvironment (TME) significantly impacts cancer progression and overall patient survival. However, the complexity of tumor cell-TME inte...
Muscle-Invasive Bladder Cancer (MIBC) is a heterogeneous disease with distinct molecular subtypes influencing prognosis and therapeutic response. Howe...
Extracellular vesicles (EVs) mediate tumor-immune cell communication by carrying protein cargo that can immediately modulate signaling and antigen pre...
Controlled exit from and re-entry into the cell cycle is essential for multi-cellular life, while aberrant quiescent and senescent cell states have be...
New systematic profiling of drug effects is in urgent demand due to limitations in existing drug assessment approaches to evaluate comprehensive drug ...
Organisation and dynamics of chromatin play a key role in regulation of cell state and function. In cancer, chromatin plasticity is known to be import...
Acute myeloid leukemia (AML) often enters remission after chemotherapy but frequently relapses due to chemotherapy-resistant leukemic stem cells (LSCs...
The selection of an effective adjuvant is a critical bottleneck in vaccine development, particularly for emerging diseases where experimental data is ...
The concomitant development and evolution of lung computed tomography (CT) and artificial intelligence (AI) has allowed non-invasive lung imaging to b...
Conventional chemotherapeutics exploit cancer’s hallmark of active cell cycling, primarily targeting mitotic cells. Consequently, the mitotic index (M...
The prognostic significance of tumor-infiltrating lymphocytes (TILs) in breast cancer has been recognized for over a decade. Although histology-based ...
In the field of medical crowdfunding prediction, traditional statistical methods have long been the standard. Machine learning algorithms are popular ...
Acute Hepatic Porphyria (AHP) is a rare genetic disease characterized by unpredictable life-threatening attacks. There is no reliable biochemical scre...
To prevent clozapine-induced agranulocytosis (CIA), patients’ white blood cell counts are closely monitored, with treatment stopped if the absolute ne...
Introduction: Achieving equity in translational precision medicine requires the integration of genomic, clinical, and social determinants of health (S...
Adjuvant use of bone-modifying agents (BMAs) to early-stage breast cancer (eBC) aims to maintain bone density, leading to prevention of bone metastasi...
Genomic testing has transformed treatment decisions for hormone receptor-positive, HER2-negative (HR+/HER2-) early breast cancer; however, it remains ...